Communication: Melatonin, Hyperhomocysteinemia, Thioretinaco Ozonide, Adenosylmethionine and Mitochondrial Dysfunction in Aging and Dementia

被引:0
作者
McCully, Kilmer S. [1 ,2 ]
机构
[1] Harvard Med Sch, Boston Vet Affairs Med Ctr, Pathol & Lab Med Serv, Boston, MA USA
[2] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA
关键词
adenosylmethionine; aging; dementia; diallyl trisulfide; homocysteine; melatonin; metformin; mitochondrial membrane potential; mitochondrial permeability transition pore; nicotinamide adenine dinucleotide; oxidative phosphorylation; thioretinaco ozonide; thioretinamide; PERMEABILITY TRANSITION PORE; 2'; 3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; RAT-BRAIN MITOCHONDRIA; S-ADENOSYLMETHIONINE; CHEMICAL PATHOLOGY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HOMOCYSTEINE; INHIBITION; ACTIVATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The indoleamine hormone melatonin is synthesized by the pineal gland, controls circadian rhythm, and is dependent upon adenosyl methionine for enzymatic synthesis of melatonin from N-acetyl serotonin. Pineal melatonin secretion declines dramatically with aging and dementia. Elevated plasma homocysteine is a risk factor for atherosclerosis and Alzheimer's disease, and the marked decline in adenosyl methionine with aging leads to dysregulation of methionine metabolism and hyperhomocysteinemia. Thioretinaco ozonide is a disulfonium complex formed from thioretinamide, cobalamin, and ozone, which binds the alpha and gamma-phosphate groups of adenosine triphosphate (ATP) and oxygen in the process of oxidative phosphorylation within mitochondria. Decreased adenosyl methionine concentrations with aging are attributed to the loss of thioretinaco ozonide from mitochondria, impairing adenosyl methionine synthesis from thioretinaco ozonide and ATP. Melatonin is present in mitochondria, where it inhibits the opening of the mitochondrial permeability transition pore, explaining its anti-oxidant and anti-apoptotic effects by reducing oxygen consumption, restoration of membrane potential and reduction of superoxide production. In aging, the enzyme cyclic nucleotide phosphodiesterase is lost from mitochondria by the opening of the permeability transition pore and disruption of the outer mitochondrial membrane, a process that is inhibited by melatonin. Thioretinaco ozonide is progressively lost from dysfunctional mitochondria by disruption of the outer mitochondrial membrane, explaining its depletion during the aging process. Accordingly, the anti-aging effects of diallyl trisulfide and metformin are attributable to inhibition of the opening of the mitochondrial permeability transition pore, preventing loss of thioretinaco ozonide from mitochondria. The hyperhomocysteinemia and suppressed immunity that are observed in atherosclerosis and dementia are attributed to the deficiency of adenosylmethionine caused by increased polyamine synthesis and decreased nitric oxide synthesis by host cells infected with pathogenic microbes. According to this analysis, the critical loss of thioretinaco ozonide from mitochondria through the opening of the permeability transition pore and disruption of the outer mitochondrial membrane by decreased melatonin secretion leads to the impaired oxidative phosphorylation, oxidative stress, calcium influx, apoptosis and mitochondrial dysfunction observed in aging and dementia.
引用
收藏
页码:126 / 131
页数:6
相关论文
共 38 条
  • [1] Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for antiapoptotic effects of melatonin
    Andrabi, SA
    Sayeed, I
    Siemen, D
    Wolf, G
    Horn, TFW
    [J]. FASEB JOURNAL, 2004, 18 (03) : 869 - +
  • [2] If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice
    Anisimov, Vladimir N.
    Berstein, Lev M.
    Popovich, Irina G.
    Zabezhinski, Mark A.
    Egormin, Peter A.
    Piskunova, Tatiana S.
    Semenchenko, Anna V.
    Tyndyk, Margarita L.
    Yurova, Maria N.
    Kovalenko, Irina G.
    Poroshina, Tatiana E.
    [J]. AGING-US, 2011, 3 (02): : 148 - 157
  • [3] Ca2+-dependent permeability transition regulation in rat brain mitochondria by 2′,3′-cyclic nucleotides and 2′,3′-cyclic nucleotide 3′-phosphodiesterase
    Azarashvili, Tamara
    Krestinina, Olga
    Galvita, Anastasia
    Grachev, Dmitry
    Baburina, Yulia
    Stricker, Rolf
    Evtodienko, Yuri
    Reiser, Georg
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 296 (06): : C1428 - C1439
  • [4] 2′,3′-Cyclic nucleotide 3′-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging
    Baburina, Yulia
    Odinokova, Irina
    Azarashvili, Tamara
    Akatov, Vladimir
    Lemasters, John J.
    Krestinina, Olga
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2017, 1859 (01): : 94 - 103
  • [5] Mitochondrial 2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNP) interacts with mPTP modulators and functional complexes (I-V) coupled with release of apoptotic factors
    Baburina, Yulia
    Azarashvili, Tamara
    Grachev, Dmitry
    Krestinina, Olga
    Galvita, Anastasya
    Stricker, Rolf
    Reiser, Georg
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2015, 90 : 46 - 55
  • [6] S-ADENOSYLMETHIONINE IN BRAIN AND OTHER TISSUES
    BALDESSARINI, RJ
    KOPIN, IJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1966, 13 (08) : 769 - +
  • [7] Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels
    Baydas, G
    Reiter, RJ
    Akbulut, M
    Tuzcu, M
    Tamer, S
    [J]. NEUROSCIENCE, 2005, 135 (03) : 879 - 886
  • [8] Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]
  • [9] S-ADENOSYLMETHIONINE IN HUMAN BLOOD
    BOHUON, C
    CAILLARD, L
    [J]. CLINICA CHIMICA ACTA, 1971, 33 (01) : 256 - +
  • [10] HYPERHOMOCYSTEINAEMIA IN STROKE - PREVALENCE, CAUSE, AND RELATIONSHIPS TO TYPE OF STROKE AND STROKE RISK-FACTORS
    BRATTSTROM, L
    LINDGREN, A
    ISRAELSSON, B
    MALINOW, MR
    NORRVING, B
    UPSON, B
    HAMFELT, A
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (03) : 214 - 221